GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syngene International Ltd (BOM:539268) » Definitions » ROE % Adjusted to Book Value

Syngene International (BOM:539268) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International ROE % Adjusted to Book Value?

Syngene International's ROE % for the quarter that ended in Dec. 2024 was 11.93%. Syngene International's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Syngene International's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.


Syngene International ROE % Adjusted to Book Value Historical Data

The historical data trend for Syngene International's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International ROE % Adjusted to Book Value Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 2.11 1.79 2.04 1.96

Syngene International Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.68 - 1.18 -

Competitive Comparison of Syngene International's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Syngene International's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Syngene International's ROE % Adjusted to Book Value falls into.


';

Syngene International ROE % Adjusted to Book Value Calculation

Syngene International's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.95% / 6.60
=1.96%

Syngene International's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.93% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Syngene International's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International Headlines

No Headlines